Featured CME Progams

Upcoming CME Events

20th Annual Highlights of the 2021 San Antonio Breast Cancer Symposium

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this virtual CME is designed to help medical, radiation and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2021 San Antonio Breast Cancer Symposium into practice.

Join speakers from Fox Chase and Penn Medicine’s Abramson Cancer Center as they present information on the treatment of breast cancer, including screening, prevention, local control, chemotherapy, hormonal therapy, and advances in breast cancer biologics and their impact on breast cancer management.

Download the Event Flyer [PDF]


Thursday, January 20, 2022

  • 5:30-9:00 PM - Exhibit Hall Open
  • 6:30-9:00 PM - Education Program
  • 9:00-9:30 PM - Virtual Reception & Exhibit Hall

Register Now


Program Director

Lori J. Goldstein, MD, FASCO
Professor Emerita, Department of Hematology/Oncology, Fox Chase Cancer Center

Fox Chase Cancer Center Faculty

Richard J. Bleicher, MD, FACS
Professor, Department of Surgical Oncology; Leader, Breast Cancer Program; Director, Breast Fellowship Program

Lori J. Goldstein, MD, FASCO
Professor Emerita, Department of Hematology/Oncology, Fox Chase Cancer Center

Elias Obeid, MD, MPH
Interim Chief, Division of Breast Medical Oncology; Assistant Professor, Department of Clinical Genetics and Department of Hematology/Oncology; Director, Breast, Ovarian and Prostate Cancer Risk Assessment

Kristen D. Whitaker, MD, MS
Assistant Professor, Department of Clinical Genetics and Department of Hematology/Oncology

Penn Medicine's Abramson Cancer Center Faculty

Susan M. Domchek, MD
Executive Director, Basser Center for BRCA; Director, MacDonald Cancer Risk Evaluation Center; Basser Professor in Oncology

Angela DeMichele, MD, MSCE
Jill & Alan Miller Endowed Chair in Breast Cancer Excellence; Professor of Medicine; Co-Leader, Breast Cancer Program; Co-Director, 2-PREVENT Translational Center of Excellence

Learning Objectives

After attending this program, participants should be able to:

  • Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
  • When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
  • Analyze new developments in breast cancer research and current available clinical trials and, when clinically relevant, include this information in discussions with patients.


Lucia Tono, PhD, MEd: 215-728-3797

Optimizing Treatment Strategies for Metastatic and Non-Metastatic Prostate Cancer

Join us for this virtual CME, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the main facets of prostate cancer management as well as the latest advances and treatments for treating this disease.


Date and registration info coming soon!


The faculty includes nationally recognized urologic, radiation and medical oncologists. They are prominent leaders and committee members in organizations, such as NCCN, AJCC and AUA. These clinicians are instrumental in writing national guidelines for GU cancer care.


  • Advanced Surgical Techniques for Definitive Treatment of Localized Prostate Cancer
  • Adjuvant vs. Salvage Radiation Therapy for Prostate Cancer: New Data
  • The Role of Genetic Evaluations and Counseling for Men With Prostate Cancer
  • Data Behind the Approvals of Key Hormonal, Chemotherapeutic and Targeted Systemic Treatments for Advanced Disease
  • New Imaging Technology in Prostate Cancer


Lucia Tono, PhD, MEd: 215-728-3797

Connect with Fox Chase